XML 57 R46.htm IDEA: XBRL DOCUMENT
v3.25.3

Commitments and Contingencies - License Agreements (Details) - Related party - KMPL | Mar. 27, 2023 item
--- | ---
Commitments and Contingencies |
Number of clinical test drug candidates granted for the use, sale, or offer of sale in India | 2
Percentage of clinical trials fees | 30.00%
Percentage of royalty fee | 70.00%

X
- Definition The line item information about commitment and contingencies. + References No definition available. + Details
Name: | nnvc_CommitmentsAndContingenciesLineItems
Namespace Prefix: | nnvc_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The number of clinical test drug candidates granted for the use, sale, or offer of sale in India. + References No definition available. + Details
Name: | nnvc_NumberOfClinicalTestDrugCandidatesGrantedForUseSaleOrOfferOfSaleInIndia
Namespace Prefix: | nnvc_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition Percentage of clinical trials manager fee. + References No definition available. + Details
Name: | nnvc_PercentageOfClinicalTrialsFees
Namespace Prefix: | nnvc_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage of royalty fee paid. + References No definition available. + Details
Name: | nnvc_PercentageOfRoyaltyFee
Namespace Prefix: | nnvc_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=nnvc_KarveerMeditechPvt.LtdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |